NEW DELHI: The Delhi government has floated a worldwide expression of interest (EOI) for procurement of Covid-19 vaccine on a urgent basis.
The supplied Covid-19 vaccine has to be approved by competent authority of the government of India, the Directorate General of Health Services stated from the EOI document.
“The Health and Family Welfare Department of NCT of Delhi plans to secure SARS-Cov2 vaccine on a urgent basis to control and purge the spread of this COVID-19 pandemic.
International Expression of Interest will be invited from global producers of COVID-19 disease or their licensed representatives or by direct importers with proper license to export the vaccine from India,” the report.
The bidders are requested to submit their deal or expression of curiosity during email by 5 pm June 7.
The central government has thus far accepted three vaccines to be used in India — both Covishield, Covaxin and also Russia’s Sputnik V.
The Serum Institute of India (SII) creates Covishield (under license from AstraZeneca), although Bharat Biotech creates the indigenously-developed Covaxin.
Delhi has up to now obtained 47.
44 lakh doses by the Centre for all those aged over 45, and health care and frontline employees.
Obviously, 44.
76 lakh doses are utilised up to now.
The city authorities had frozen the inoculation work out to the 18-44 age class May 22 after it ran out of experiments for this particular group.
Until today, 8.
17 lakh dosages are secured directly from the producers for the 18-44 age category.
The funds is very likely to have approximately four lakh more dosages to this class in the producers in India in June.
Based on information shared with the Centre, 52.
98 lakh doses are administered in Delhi because the inoculation exercise began on January 16.
Obviously, 36.
92 lakh have been Covishield dosages along with 16.
06 were Covaxin jabs.
The most amount of 1.
41 lakh individuals were vaccinated May 10.